These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
189 related articles for article (PubMed ID: 37429747)
1. Utilization outcomes of direct oral anticoagulants in Medicare patients. Arora P; Muehrcke M; Russell M; Ghanekar S Res Social Adm Pharm; 2023 Nov; 19(11):1424-1431. PubMed ID: 37429747 [TBL] [Abstract][Full Text] [Related]
2. Comparison of Drug Switching and Discontinuation Rates in Patients with Nonvalvular Atrial Fibrillation Treated with Direct Oral Anticoagulants in the United States. Baker CL; Dhamane AD; Mardekian J; Dina O; Russ C; Rosenblatt L; Lingohr-Smith M; Menges B; Lin J; Nadkarni A Adv Ther; 2019 Jan; 36(1):162-174. PubMed ID: 30499067 [TBL] [Abstract][Full Text] [Related]
3. Comparison of differences in medical costs when new oral anticoagulants are used for the treatment of patients with non-valvular atrial fibrillation and venous thromboembolism vs warfarin or placebo in the US. Amin A; Bruno A; Trocio J; Lin J; Lingohr-Smith M J Med Econ; 2015 Jun; 18(6):399-409. PubMed ID: 25586203 [TBL] [Abstract][Full Text] [Related]
4. Drug Utilization Pattern of Oral Anticoagulants in Patients with Atrial Fibrillation: A Nationwide Population-Based Study in Korea. Lee MY; Han S; Bang OY; On YK; Jang SW; Han S; Ryu J; Park YJ; Kang S; Suh HS; Kim YH Adv Ther; 2022 Jul; 39(7):3112-3130. PubMed ID: 35524839 [TBL] [Abstract][Full Text] [Related]
5. Healthcare resource utilization and expenditures among newly-diagnosed elderly non-valvular atrial fibrillation patients initiating oral anticoagulants. Chowdhury R; Franchino-Elder J; Wang L; Yuce H; Wang C; Hartaigh BO J Med Econ; 2019 Dec; 22(12):1338-1350. PubMed ID: 31549883 [No Abstract] [Full Text] [Related]
6. Adherence to Rivaroxaban Compared with Other Oral Anticoagulant Agents Among Patients with Nonvalvular Atrial Fibrillation. McHorney CA; Ashton V; Laliberté F; Germain G; Wynant W; Crivera C; Schein JR; Lefebvre P; Peterson ED J Manag Care Spec Pharm; 2017 Sep; 23(9):980-988. PubMed ID: 28854075 [TBL] [Abstract][Full Text] [Related]
7. Direct Oral Anticoagulant (DOAC) Dosing in Patients with Non-valvular Atrial Fibrillation (NVAF) in the United Kingdom: A Retrospective Cohort Study Using CPRD Gold Database. Khachatryan A; Doobaree IU; Spentzouris G; Gusto G; Zawaneh Y; Mughal F; Anastassopoulou A; Manu M; Fay M Adv Ther; 2023 Feb; 40(2):504-520. PubMed ID: 36399317 [TBL] [Abstract][Full Text] [Related]
8. Comparative clinical outcomes between direct oral anticoagulants and warfarin among elderly patients with non-valvular atrial fibrillation in the CMS medicare population. Amin A; Keshishian A; Dina O; Dhamane A; Nadkarni A; Carda E; Russ C; Rosenblatt L; Mardekian J; Yuce H; Baker CL J Thromb Thrombolysis; 2019 Aug; 48(2):240-249. PubMed ID: 30924051 [TBL] [Abstract][Full Text] [Related]
9. Current status of oral anticoagulant adherence in Japanese patients with atrial fibrillation: A claims database analysis. Yagi N; Suzuki S; Nagai K; Tanaka T; Nagahama T; Arita T; Otsuka T; Yamashita T J Cardiol; 2021 Aug; 78(2):150-156. PubMed ID: 33663881 [TBL] [Abstract][Full Text] [Related]
10. A Real-World Observational Study of Hospitalization and Health Care Costs Among Nonvalvular Atrial Fibrillation Patients Prescribed Oral Anticoagulants in the U.S. Medicare Population. Amin A; Keshishian A; Trocio J; Dina O; Le H; Rosenblatt L; Liu X; Mardekian J; Zhang Q; Baser O; Nadkarni A; Vo L J Manag Care Spec Pharm; 2018 Sep; 24(9):911-920. PubMed ID: 30156450 [TBL] [Abstract][Full Text] [Related]
11. Use of direct oral anticoagulants in patients with atrial fibrillation in Scotland: Applying a coherent framework to drug utilisation studies. Mueller T; Alvarez-Madrazo S; Robertson C; Bennie M Pharmacoepidemiol Drug Saf; 2017 Nov; 26(11):1378-1386. PubMed ID: 28752670 [TBL] [Abstract][Full Text] [Related]
12. Comparative effectiveness of direct oral anticoagulants and warfarin in patients with cancer and atrial fibrillation. Shah S; Norby FL; Datta YH; Lutsey PL; MacLehose RF; Chen LY; Alonso A Blood Adv; 2018 Feb; 2(3):200-209. PubMed ID: 29378726 [TBL] [Abstract][Full Text] [Related]
13. High number of newly initiated direct oral anticoagulant users switch to alternate anticoagulant therapy. Manzoor BS; Walton SM; Sharp LK; Galanter WL; Lee TA; Nutescu EA J Thromb Thrombolysis; 2017 Nov; 44(4):435-441. PubMed ID: 29027097 [TBL] [Abstract][Full Text] [Related]
14. Dose specific effectiveness and safety of DOACs in patients with non-valvular atrial fibrillation: A Canadian retrospective cohort study. Rahme E; Godin R; Nedjar H; Dasgupta K; Tagalakis V Thromb Res; 2021 Jul; 203():121-130. PubMed ID: 34000493 [TBL] [Abstract][Full Text] [Related]
15. Adherence to Rivaroxaban, Dabigatran, and Apixaban for Stroke Prevention in Incident, Treatment-Naïve Nonvalvular Atrial Fibrillation. Brown JD; Shewale AR; Talbert JC J Manag Care Spec Pharm; 2016 Nov; 22(11):1319-1329. PubMed ID: 27783556 [TBL] [Abstract][Full Text] [Related]
16. Effectiveness and Safety of Four Direct Oral Anticoagulants in Asian Patients With Nonvalvular Atrial Fibrillation. Chan YH; Lee HF; See LC; Tu HT; Chao TF; Yeh YH; Wu LS; Kuo CT; Chang SH; Lip GYH Chest; 2019 Sep; 156(3):529-543. PubMed ID: 31103697 [TBL] [Abstract][Full Text] [Related]
17. Discontinuation of non-Vitamin K antagonist oral anticoagulants in patients with non-valvular atrial fibrillation: a population-based cohort study using primary care data from The Health Improvement Network in the UK. Ruigómez A; Vora P; Balabanova Y; Brobert G; Roberts L; Fatoba S; Fernandez O; García Rodríguez LA BMJ Open; 2019 Oct; 9(10):e031342. PubMed ID: 31630107 [TBL] [Abstract][Full Text] [Related]
18. Effectiveness and Safety of Anticoagulants in Adults with Non-valvular Atrial Fibrillation and Concomitant Coronary/Peripheral Artery Disease. Lopes RD; Steffel J; Di Fusco M; Keshishian A; Luo X; Li X; Masseria C; Hamilton M; Friend K; Gupta K; Mardekian J; Pan X; Baser O; Jones WS Am J Med; 2018 Sep; 131(9):1075-1085.e4. PubMed ID: 29807001 [TBL] [Abstract][Full Text] [Related]
19. Effectiveness and Safety of Direct Oral Anticoagulants Among Patients with Non-valvular Atrial Fibrillation and Multimorbidity. Dhamane AD; Ferri M; Keshishian A; Russ C; Atreja N; Gutierrez C; Emir B; Yuce H; Di Fusco M Adv Ther; 2023 Mar; 40(3):887-902. PubMed ID: 36527598 [TBL] [Abstract][Full Text] [Related]
20. Risk of stroke/systemic embolism, major bleeding and associated costs in non-valvular atrial fibrillation patients who initiated apixaban, dabigatran or rivaroxaban compared with warfarin in the United States Medicare population. Amin A; Keshishian A; Trocio J; Dina O; Le H; Rosenblatt L; Liu X; Mardekian J; Zhang Q; Baser O; Vo L Curr Med Res Opin; 2017 Sep; 33(9):1595-1604. PubMed ID: 28635338 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]